Transcatheter aortic valve replacement (TAVR) delivery systems are used to deliver replacement aortic valves to the aortic valve annulus using an intravascular approach. There are certain challenges associated with use of currently available TAVR delivery systems. In some patients, imprecise non-orthogonal placement of the TAVR device in the aortic valve annulus can cause paravalvular leak (PVL) and complete heart block (CHB). Impingement on the septum during valve expansion can create injury to the His bundle, resulting in the need for a permanent pacemaker. Precise positioning and orientation of the TAVR valve at the target site is highly desirable for avoiding such potential complications.
Commonly owned co-pending U.S. application Ser. No. 16/365,601 describes a transseptal delivery system for driving aortic valve therapeutic devices (AVTD's) such as TAVR delivery systems into place using a combination of pulling force, pushing force, steering force, and momentum. A related system that is used instead for transeptally driving transvascular mitral valve replacement (TMVR) valves or other mitral valve therapeutic devices into place is described in Applicant's co-pending application Ser. No. 16/396,677. Another co-pending U.S. application Ser. No. 16/578,373 describes a transseptal delivery system and method that may be used to deliver percutaneous ventricular assist devices, or other devices such as aortic valve therapeutic devices or mitral valve therapeutic devices to their target locations.
Commonly owned U.S. application Ser. No. 17/214,899 describes a method of using a system that is similar to that described in U.S. application Ser. No. 16/578,373 for delivering an aortic valve therapeutic device, such as a TAVR delivery system carrying a TAVR valve, to an aortic valve site using a modified approach to the aortic valve site. More particularly, the therapeutic device is introduced into the vasculature on the arterial side (e.g., via the right femoral artery “RFA”) vs the venous side as described in the prior co-pending applications. That system and method allow the TAVR delivery system to be precisely maneuvered coaxially into the center of the native or a prosthetic aortic valve, orthogonal to the aortic valve annulus and away from the subvalvular conduction system.
The presently disclosed steering catheter is designed to aid in the delivery of a TAVR device, other aortic valve therapeutic device or cardiac therapeutic devices to a location within the heart, such as at the aortic valve. A steering catheter has features similar to those of the “LVR” device described in U.S. application Ser. No. 16/365,601, U.S. application Ser. No. 16/578,373, and U.S. application Ser. No. 17/214,899, but it may differ in certain ways. In general, changes to its dimension and material properties, pullwire arrangement and handle may also be made without departing from the scope of the present invention. Additionally, the steering catheter differs from the LVR described in the referenced applications in ways that will be described with reference to
Referring to
The return wire is positioned 180° from the pull wires as shown. It may have a rectangular diameter with the long edges oriented to cause the shaft to preferentially bend along bending plane P1. One of the pullwires 314a exits and then re-enters the shaft towards the shaft's distal end. This will be explained in the description of
An outer jacket 318 of polymeric material (e.g., polyether block amide, “PEBA,” such as that sold under the brand name Pebax) 314 covers the braid 312. During manufacture of the shaft, the polymeric material is positioned over the braid and subjected to a reflow process to flow the polymeric material over the braid. The material properties of the polymeric material vary along the length of the shaft. This is discussed in detail in the prior applications referenced above.
The distal end of the shaft is moveable between the generally straight position shown in
One of the pullwires 314a exits the sidewall of the shaft near the shaft's distal end, runs along the exterior of the shaft in a distal direction, and re-enters the shaft at the distal end of the shaft, while the other pull wire 314b does not exit the shaft at the distal end. The dual pull wire configuration advantageously allows articulation to the desired curvature and locking of the articulation in that curvature despite high loads experienced at the tip of the device during use.
The pull wire 314b that remains inside the shaft (“internal pull wire”) helps maintain the patency of the shaft's lumen during articulation, preventing the shaft from buckling or kinking despite the large degree of articulation as would likely happen if the construction used only the external pull wire.
The pullwire 314a that exits the shaft (the “external pull wire”) functions as a locking mechanism to lock the shaft in its articulated orientation, preventing the curve from opening when forces are exerted against the distal tip of the shaft. Another, related, feature is that when its tip is subjected to the forces described in the prior paragraph, the length of the pull wire 314b that is exposed outside the shaft 138 remains generally constant.
Note that the terms “pullwire” and “wire” are not intended to mean that the pullwires must be formed of wire, as these terms are used more broadly in this application to represent any sort of tendon, cable, or other elongate element the tension on which may be adjusted to change the shape of the catheter. Also, while the term “straight” is used to refer to the shape of the catheter shaft's distal portion in its non-articulated position, it should be pointed out that the catheter's inherent flexibility in the non-articulated position may cause it to bend under forces of gravity when held upright, or to curve when tracked over a curved cable or wire, or advanced into contact with another structure. The term “straight” thus should not be used to interpret this application or the corresponding claims as requiring that portion of the shaft to hold a straight shape.
Referring to
Another distinction from the LVR described in the prior applications is a protective feature on the external pullwire. More specifically, the external pullwire 314a, which runs external to the shaft 138 in the distal part of the device 136 has a protective covering C, as shown in
Steering catheters of the type described herein may be used to deliver TAVR delivery systems or TMVR delivery systems to delivery sites within the heart. Once those delivery systems are delivered to the target sites using the steering catheter, the mechanisms of those delivery systems are activated in order to deliver the valve carried by the delivery system to the valve site.
In this section, a method of using a system of this type to deliver a TAVR delivery system carrying a TAVR device to the aortic valve site the heart will first be described. Afterwards, a method of using such the system to deliver a TMVR valve delivery system carrying a TMVR valve to its operative location within the heart will be described. It should be understood that these methods can be carried out using alternative steering catheters, and so it should be understood that this description is not limited to methods using the disclosed embodiments. Moreover, it should be understood that steps from the disclosed methods may be eliminated, and/or other steps may be added, without departing from the scope of the present invention. Because in these examples the steering catheter is used in an antegrade direction, the below examples refer to it as an “antegrade steering catheter” or “ASC.”
This first example describes use of an antegrade steering catheter that has been placed into the left ventricle through the mitral valve as an accessory to guide the placement of transvascular aortic valve replacement (TAVR) valves and other aortic valve therapeutic devices
1. Place a 14 French access sheath in both the right femoral vein and the right femoral artery
2. Advance the ASC catheter and dilator through the venous sheath over a standard 0.035 steerable exchange guidewire (SEGW) to the inter-atrial septum.
3. Using intra-cardiac echo (ICE) for guidance, utilize a Brockenbrough style needle to enter the left atrium and then advance the SEGW into the left atrium followed by the ASC catheter.
4. Remove the dilator from the ASC catheter and replace it with a standard peripheral angioplasty balloon catheter and perform a standard atrial septostomy.
5. Advance the ASC catheter into the left atrium (LA) past the mitral valve orifice and retract both the balloon and SEGW into the ASC catheter.
6. Articulate the ASC catheter 90 degrees to the first position shown in
7. Extend a small amount of the SEGW out of the end of the balloon and advance the tip of the balloon for 1.5 cm past the tip of the ASC catheter and inflate the balloon to between 1 and 2 atm to a diameter of 10-12 mm and advance the balloon and ASC catheter together to identify a clear pathway through the chordae tendineae and into the left ventricle in order to avoid chordal entrapment.
8. Articulate and torque the ASC toward the aortic valve (AV) and advance the SEGW retrograde through the aortic valve and around the aortic arch to the descending aorta.
9. Snare the SEGW from the arterial sheath and place the TAVR device over the SEGW, locking it onto the wire with the Tuohy Borst valve and advance it through the aorta to the level of the aortic valve as the guidewire is simultaneously retracted from the venous end of the ASC catheter.
10. Deploy the external pullwire to the position shown in
The second example describes placement of an antegrade steering catheter into the left ventricle through the aortic valve as an accessory to guide the placement of transvascular mitral valve replacement (TMVR) valves and other mitral valve therapeutic devices
1. Repeat steps 1-8 above to be able to advance the SEGW to the descending aorta without chordal entrapment, then snare the SEGW and withdraw it from the arterial sheath.
2. Remove the ASC catheter from the venous access sheath, leaving only the SEGW in the body as an “AV loop”, then reinstall the dilator and advance the ASC catheter retrograde across the aortic valve. Remove the dilator, and seat the articulated ASC catheter in the apex.
3. Place the TMVR device over the venous side of the SEGW and lock it onto the wire with the Tuohy Borst valve
4. Deploy the external pullwire to the position shown in
All prior patents and applications referenced herein are incorporated herein by reference.
This application claims the benefit of U.S. Provisional Application No. 63/191,903, filed May 21, 2021, which is incorporated herein by reference. Inventor: Richard S. Stack, William L. Athas, Kevin W. Johnson
Number | Date | Country | |
---|---|---|---|
63191903 | May 2021 | US |